The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Cognitive dysfunction and dementia in Parkinson?s disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Storage and Executive Processes in the Frontal Lobes
Smith, E. E., & Jonides, J. (1999) · Science · doi:10.1126/science.283.5408.1657 · Cited by 2,834
Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6)
Mesulam, M.-M., Mufson, E. J., Wainer, B. H., & Levey, A. I. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90108-2 · Cited by 2,328
Frontal-subcortical circuits and human behavior
Cummings, J. L. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540080076020 · Cited by 2,262
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Circuitry of Primate Prefrontal Cortex and Regulation of Behavior by Representational Memory
Goldman‐Rakic, P. S. (1987) · Comprehensive Physiology · doi:10.1002/cphy.cp010509 · Cited by 1,960 · cited 1×
“Recent studies with the cholinesterase inhibitors galantamine, donepezil and rivastigmine show promising results in improving cognition and ameliorating psychotic symptoms, which must further be confirmed in randomized controlled trials.”
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618
Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,401
McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R., & Spiegel, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03399-7 · Cited by 1,182
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity
Oades, R. D., & Halliday, G. M. (1987) · Brain Research Reviews · doi:10.1016/0165-0173(87)90011-7 · Cited by 1,008
A 5-month, randomized, placebo-controlled trial of galantamine in AD
Tariot, P. N., Solomon, P. R., Morris, J. C., Kershaw, P., Lilienfeld, S., Ding, C., & the Galantamine USA- Study Group (2000) · Neurology · doi:10.1212/wnl.54.12.2269 · Cited by 921
Cognitive deficits in Parkinson’s disease
Dubois, B., & Pillon, B. (1996) · Journal of Neurology · doi:10.1007/pl00007725 · Cited by 903
FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASE: THE CORTICAL FOCUS OF NEOSTRIATAL OUTFLOW
TAYLOR, A. E., SAINT-CYR, J. A., & LANG, A. E. (1986) · Brain · doi:10.1093/brain/109.5.845 · Cited by 882
‘Frontal' cognitive function in patients with Parkinson's disease ‘on' and ‘off' levodopa
GOTHAM, A. M., BROWN, R. G., & MARSDEN, C. D. (1988) · Brain · doi:10.1093/brain/111.2.299 · Cited by 835
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb06891.x · Cited by 811
Scatton, B., Javoy-Agid, F., Rouquier, L., Dubois, B., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90993-9 · Cited by 726
Risk of dementia in Parkinson’s disease: A community-based, prospective study
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721
Lange, K. W., Robbins, T. W., Marsden, C. D., James, M., Owen, A. M., & Paul, G. M. (1992) · Psychopharmacology · doi:10.1007/bf02245167 · Cited by 610
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
Hurtig, H. I., Trojanowski, J. Q., Galvin, J., Ewbank, D., Schmidt, M. L., Lee, V. M. Y., Clark, C. M., Glosser, G., Stern, M. B., Gollomp, S. M., et al. (2000) · Neurology · doi:10.1212/wnl.54.10.1916 · Cited by 601
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Chan‐Palay, V., & Asan, E. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902870308 · Cited by 495
Mental symptoms in Parkinson's disease are important contributors to caregiver distress
Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199910)14:10<866::aid-gps38>3.0.co;2-z · Cited by 487
Kuhl, D. E., Minoshima, S., Fessler, J. A., Ficaro, E. P., Wieland, D. M., Koeppe, R. A., Frey, K. A., & Foster, N. L. (1996) · Annals of Neurology · doi:10.1002/ana.410400309 · Cited by 426
Parkinson Disease Neuropathology: Later-Developing Dementia and Loss of the Levodopa Response
Apaydin, H., Ahlskog, J. E., Parisi, J. E., Boeve, B. F., & Dickson, D. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.102 · Cited by 399
Mayeux, R. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290076015 · Cited by 383
A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease
Hughes, T. A., Ross, H. F., Musa, S., Bhattacherjee, S., Nathan, R. N., Mindham, R. H. S., & Spokes, E. G. S. (2000) · Neurology · doi:10.1212/wnl.54.8.1596 · Cited by 372
Mattila, P. M., Rinne, J. O., Helenius, H., Dickson, D. W., Röyttä, M., & Mattila, P. M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900168 · Cited by 361
Spatial and non-spatial working memory at different stages of Parkinson's disease
Owen, A. M., Iddon, J. L., Hodges, J. R., Summers, B. A., & Robbins, T. W. (1997) · Neuropsychologia · doi:10.1016/s0028-3932(96)00101-7 · Cited by 355
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
Aarsland, D. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.708 · Cited by 341
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
Rinne, J. O., Mlic, J. R., Paljärvi, L., & Rinne, U. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260107 · Cited by 331
Cholinergic dysfunction in diseases with Lewy bodies
Tiraboschi, P., Hansen, L. A., Alford, M., Sabbagh, M. N., Schoos, B., Masliah, E., Thal, L. J., & Corey-Bloom, J. (2000) · Neurology · doi:10.1212/wnl.54.2.407 · Cited by 328
Explicit Memory in Alzheimer's, Huntington's, and Parkinson's Diseases
Pillon, B., Deweer, B., Agid, Y., & Dubois, B. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540040036010 · Cited by 316
Rogers, R. (1998) · Brain · doi:10.1093/brain/121.5.815 · Cited by 312
Attention to action in Parkinson’s disease
Rowe, J., Stephan, K. E., Friston, K., Frackowiak, R., Lees, A., & Passingham, R. (2002) · Brain · doi:10.1093/brain/awf036 · Cited by 300
Owen, A. (1998) · Brain · doi:10.1093/brain/121.5.949 · Cited by 299
Litvan, I., MacIntyre, A., Goetz, C. G., Wenning, G. K., Jellinger, K., Verny, M., Bartko, J. J., Jankovic, J., McKee, A., Brandel, J. P., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.969 · Cited by 298
Cortical Lewy body pathology in the diagnosis of dementia
Harding, A. J., & Halliday, G. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100390 · Cited by 297
Visuospatial impairment in Parkinson's disease
Levin, B. E., Llabre, M. M., Reisman, S., Weiner, W. J., Sanchez-Ramos, J., Singer, C., & Brown, M. C. (1991) · Neurology · doi:10.1212/wnl.41.3.365 · Cited by 289
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
Jellinger, K. A., Seppi, K., Wenning, G. K., & Poewe, W. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200027 · Cited by 287
Fluctuations in attention: PD dementia vs DLB with parkinsonism
Ballard, C. G., Aarsland, D., McKeith, I., O’Brien, J., Gray, A., Cormack, F., Burn, D., Cassidy, T., Starfeldt, R., Larsen, J.-P., et al. (2002) · Neurology · doi:10.1212/01.wnl.0000036908.39696.fd · Cited by 285
Visuospatial Impairment in Parkinson's Disease: Role of Perceptual and Motor Factors
Boller, F. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050170031011 · Cited by 285
Memory and executive function impairment predict dementia in Parkinson's disease
Levy, G., Jacobs, D. M., Tang, M., Côté, L. J., Louis, E. D., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2002) · Movement Disorders · doi:10.1002/mds.10280 · Cited by 282
Frequency of Dementia in Parkinson Disease
Aarsland, D., Tandberg, E., Larsen, J. P., & Cummings, J. L. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550060082020 · Cited by 280
COOPER, J. A., SAGAR, H. J., DOHERTY, S. M., JORDAN, N., TIDSWELL, P., & SULLIVAN, E. V. (1992) · Brain · doi:10.1093/brain/115.6.1701 · Cited by 275
Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases
Gaspar, P., & Gray, F. (1984) · Acta Neuropathologica · doi:10.1007/bf00695605 · Cited by 275
Reading, P. J., Luce, A. K., & McKeith, I. G. (2001) · Movement Disorders · doi:10.1002/mds.1204 · Cited by 272
Striatal contributions to working memory: a functional magnetic resonance imaging study in humans
Lewis, S. J. G., Dove, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03108.x · Cited by 272
The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease
Marder, K., Tang, M.-X., Cote, L., Stern, Y., & Mayeux, R. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310069018 · Cited by 268
The cholinergic hypothesis of Alzheimer's disease: a review of progress
BABIC;, T., FRANCIS, P. T., PALMER, A. M., SNAPE, M., & WILCOCK, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.558 · Cited by 255
Visuospatial memory deficits at different stages of Parkinson's disease
Owen, A. M., Beksinska, M., James, M., Leigh, P. N., Summers, B. A., Marsden, C. D., Quinn, N. P., Sahakian, B. J., & Robbins, T. W. (1993) · Neuropsychologia · doi:10.1016/0028-3932(93)90135-m · Cited by 252
Memory and learning in early Parkinson's disease: Evidence for a “frontal lobe syndrome”
Taylor, A. E., Saint-Cyr, J. A., & Lang, A. E. (1990) · Brain and Cognition · doi:10.1016/0278-2626(90)90051-o · Cited by 237
Aarsland, D. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1215 · Cited by 231
Motor impairment in PD: Relationship to incident dementia and age
Levy, G., Tang, M.-X., Cote, L. J., Louis, E. D., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2000) · Neurology · doi:10.1212/wnl.55.4.539 · Cited by 225
Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
Aarsland, D., Hutchinson, M., & Larsen, J. P. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.949 · Cited by 219
Parkinsonism: Effects of levodopa treatment on concept formation
BOWEN, F. P., KAMIENNY, R. S., BURNS, M. M., & YAHR, M. D. (1975) · Neurology · doi:10.1212/wnl.25.8.701 · Cited by 219
Neuropsychological prediction of dementia in Parkinson's disease
Mahieux, F., Fenelon, G., Flahault, A., Manifacier, M.-J., Michelet, D., & Boller, F. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.2.178 · Cited by 219
Perry, E. K., Irving, D., Kerwin, J. M., McKeith, I. G., Thompson, P., Collerton, D., Fairbairn, A. F., Ince, P. G., Morris, C. M., Cheng, A. V., et al. (1993) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199307020-00002 · Cited by 214
Parkinson's disease and dementia: Norepinephrine and dopamine in locus ceruleus
Cash, R., Dennis, T., L'Heureux, R., Raisman, R., Javoy-Agid, F., & Scatton, B. (1987) · Neurology · doi:10.1212/wnl.37.1.42 · Cited by 196
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
Pillon, B., Dubois, B., Cusimano, G., Bonnet, A. M., Lhermitte, F., & Agid, Y. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.2.201 · Cited by 191
An Estimate of the Prevalence of Dementia in Idiopathic Parkinson's Disease
Mayeux, R., Stern, Y., Rosenstein, R., Marder, K., Hauser, A., Cote, L., & Fahn, S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520270034017 · Cited by 190
Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease
WOODS, S. P., & TRÖSTER, A. I. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703910022 · Cited by 187
Neuropsychological characteristics of preclinical dementia in Parkinson's disease
Jacobs, D. M., Marder, K., Cote, L. J., Sano, M., Stern, Y., & Mayeux, R. (1995) · Neurology · doi:10.1212/wnl.45.9.1691 · Cited by 186
Kulisevsky, J. (2000) · Drugs & Aging · doi:10.2165/00002512-200016050-00006 · Cited by 177
VISUOSPATIAL FUNCTION IN PARKINSON'S DISEASE
BROWN, R. G., & MARSDEN, C. D. (1986) · Brain · doi:10.1093/brain/109.5.987 · Cited by 173
Metrifonate treatment of the cognitive deficits of Alzheimer's disease
Cummings, J. L., Cyrus, P. A., Bieber, F., Mas, J., Orazem, J., Gulanski, B., & The Metrifonate Study Group* (1998) · Neurology · doi:10.1212/wnl.50.5.1214 · Cited by 172
SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA
McKeith, I. G., & Burn, D. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70230-9 · Cited by 168
Parkinsonism: Alterations in spatial orientation as determined by a route-walking test
Bowen, F. P., Hoehn, M. M., & Yahr, M. D. (1972) · Neuropsychologia · doi:10.1016/0028-3932(72)90027-9 · Cited by 164
Bondi, M. W., Kaszniak, A. W., Bayles, K. A., & Vance, K. T. (1993) · Neuropsychology · doi:10.1037//0894-4105.7.1.89 · Cited by 164
An estimate of the incidence of dementia in idiopathic Parkinson's disease
Mayeux, R., Chen, J., Mirabello, E., Marder, K., Bell, K., Dooneief, G., Cote, L., & Stern, Y. (1990) · Neurology · doi:10.1212/wnl.40.10.1513 · Cited by 160
Kulisevsky, J., Garc�a-S�nchez, C., Berthier, M. L., Barbanoj, M., Pascual-Sedano, B., Gironell, A., & Est�vez-Gonz�lez, A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<613::aid-mds1005>3.0.co;2-f · Cited by 160
Burn, D. J., Rowan, E. N., Minett, T., Sanders, J., Myint, P., Richardson, J., Thomas, A., Newby, J., Reid, J., O'Brien, J. T., et al. (2003) · Movement Disorders · doi:10.1002/mds.10455 · Cited by 159
Slowed central processing in simple and go/no-go reaction time tasks in Parkinson's disease
Cooper, J. A., Sagar, H. J., Tidswell, P., & Jordan, N. (1994) · Brain · doi:10.1093/brain/117.3.517 · Cited by 159
Bullock, R., & Cameron, A. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000813 · Cited by 159
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial
McKeith, I. G., Grace, J., Walker, Z., Byrne, E. J., Wilkinson, D. G., Stevens, T., & Perry, E. K. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200005)15:5<387::aid-gps131>3.0.co;2-9 · Cited by 158
Samochocki, M., Zerlin, M., Jostock, R., Groot‐Kormelink, P. J., Luyten, W. H. M. L., Albuquerque, E. X., & Maelicke, A. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00310.x · Cited by 156
Bergman, J., & Lerner, V. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200203000-00009 · Cited by 156
Convergent cholinergic activities in aging and Alzheimer's disease
Perry, E. K., Johnson, M. H., Kerwin, J. M., Piggott, M. A., COURT, J. A., Shaw, P. J., Ince, P. G., Brown, A. J., & Perry, R. H. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90113-c · Cited by 155
Donepezil in the treatment of hallucinations and delusions in Parkinson’s disease
Fabbrini, G., Barbanti, P., Aurilia, C., Pauletti, C., Lenzi, G. L., & Meco, G. (2002) · Neurological Sciences · doi:10.1007/s100720200022 · Cited by 154
Antecedent clinical features associated with dementia in Parkinson's disease
Stern, Y., Marder, K. S., Tang, M. X., & Mayeux, R. P. (1993) · Neurology · doi:10.1212/wnl.43.9.1690 · Cited by 154
Mattila, P. M., Röyttä, M., Lönnberg, P., Marjamäki, P., Helenius, H. Y. M., & Rinne, J. O. (2001) · Acta Neuropathologica · doi:10.1007/s004010100372 · Cited by 150
Cholinesterase inhibition in Parkinson's disease.
Hutchinson, M., & Fazzini, E. P. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.3.324-a · Cited by 150
Visuospatial working memory in Parkinson's disease.
Bradley, V. A., Welch, J. L., & Dick, D. J. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.11.1228 · Cited by 147
High Speed Memory Scanning in Parkinsonism
Wilson, R. S., Kaszniak, A. W., Klawans, H. L., & Garron, D. C. (1980) · Cortex · doi:10.1016/s0010-9452(80)80022-0 · Cited by 141
Long-Term Use of Rivastigmine in Patients With Dementia With Lewy Bodies: An Open-Label Trial
Grace, J., Daniel, S., Stevens, T., Shankar, K. K., Walker, Z., Byrne, E. J., Butler, S., Wilkinson, D. G., Woolford, J., Waite, J., et al. (2001) · International Psychogeriatrics · doi:10.1017/s104161020100758x · Cited by 138
Perry, E. K., McKeith, I. G., THOMPSON, P., MARSHALL, E., Kerwin, J. M., Jabeen, S., Edwardson, J. A., Ince, P. G., Blessed, G., Irving, D., et al. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00217.x · Cited by 138
Confusion, dementia and anticholinergics in Parkinson's disease.
de Smet, Y., Ruberg, M., Serdaru, M., Dubois, B., Lhermitte, F., & Agid, Y. (1982) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.12.1161 · Cited by 133
Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease
Mattila, P. M., Röyttä, M., Torikka, H., Dickson, D. W., & Rinne, J. O. (1998) · Acta Neuropathologica · doi:10.1007/s004010050843 · Cited by 133
Psychosis in Parkinson's disease
Poewe, W. H. (2003) · Movement Disorders · doi:10.1002/mds.10567 · Cited by 127
Cognitive Profiles of Autopsy-Confirmed Lewy Body Variant vs Pure Alzheimer Disease
Connor, D. J., Salmon, D. P., Sandy, T. J., Galasko, D. R., Hansen, L. A., & Thal, L. J. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.994 · Cited by 120
Memory and learning strategies in patients with Parkinson's disease
Buytenhuijs, E. L., Berger, H. J. C., van Spaendonck, K. P. M., Horstink, M. W. I. M., Borm, G. F., & Cools, A. R. (1994) · Neuropsychologia · doi:10.1016/0028-3932(94)90135-x · Cited by 112
Rivastigmine (Exelon) for dementia in patients with Parkinson's disease
Giladi, N., Shabtai, H., Gurevich, T., Benbunan, B. R., Anca‐Herschkovitsch, M., & Korczyn, A. D. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00211.x · Cited by 99
Hansen, L. A., & Galasko, D. (1992) · PubMed · Cited by 99
Clinical and biochemical correlates of bradyphrenia in Parkinson's disease
Mayeux, R. P., Stern, Y., Sano, M. C., Cote, L. J., & Williams, J. B. W. (1987) · Neurology · doi:10.1212/wnl.37.7.1130 · Cited by 96
Neuropsychological Differences Between the Dementias of Alzheimer's and Parkinson's Diseases
Huber, S. J., Shuttleworth, E. C., & Freidenberg, D. L. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520480029015 · Cited by 90
Werber, E. A., & Rabey, J. M. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100008 · Cited by 89
Pillon, B., Deweer, B., Vidailhet, M., Bonnet, A.-M., Hahn‐Barma, V., & Dubois, B. (1998) · Neuropsychologia · doi:10.1016/s0028-3932(97)00102-4 · Cited by 88
Dementia and cognitive impairment in Parkinson's disease.
Girotti, F., Soliveri, P., Carella, F., Piccolo, I., Caffarra, P., Musicco, M., & CARACENI, T. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.12.1498 · Cited by 85
Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease
Burn, D. J., & McKeith, I. G. (2003) · Movement Disorders · doi:10.1002/mds.10566 · Cited by 78
Bédard, M., Pillon, B., Dubois, B., Duchesne, N., Masson, H., & Agid, Y. (1999) · Brain and Cognition · doi:10.1006/brcg.1999.1083 · Cited by 78
de Vos, R. A. I., Jansen, E. N. H., Stam, F. C., Ravid, R., & Swaab, D. F. (1995) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(94)00060-j · Cited by 75
Parkinson's disease and dementia with Lewy bodies: One disease or two?
Richard, I. H., Papka, M., Rubio, A. I., & Kurlan, R. (2002) · Movement Disorders · doi:10.1002/mds.10274 · Cited by 71
Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
Lange, K. W., Paul, G., Naumann, M., & Gsell, W. (1995) · PubMed · Cited by 71
Psychosis in Parkinson’s Disease
Wint, D. P., Okun, M. S., & Fernandez, H. H. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704267457 · Cited by 65
Storage and Executive Processes in the Frontal Lobes
Smith, E. E., & Jonides, J. (2002) · The MIT Press eBooks · doi:10.7551/mitpress/3077.003.0014 · Cited by 55
Dementia in idiopathic Parkinson's disease: Variables associated with its occurrence in 203 patients
Elizan, T. S., Sroka, H., Maker, H. S., Smith, H., & Yahr, M. D. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249089 · Cited by 45
Studies on mesocortical dopamine systems.
Thierry, A. M., Tassin, J., Blanc, G., & Glowinski, J. (1978) · PubMed · Cited by 37
Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditions
Gabelli, C. (2003) · Current Medical Research and Opinion · doi:10.1185/030079902125001452 · Cited by 36
Visuoperception and visuospatial and visuorotational performance in Parkinson's disease
Ransmayr, G. N., Schmidhuber-Eiler, B., Karamat, E., Pl�rer, S., Poewe, W. H., & Leidlmair, K. (1987) · Journal of Neurology · doi:10.1007/bf00718018 · Cited by 35
Set-shifting and spatial orientation in patients with Parkinson's disease
Raskin, S. A., Borod, J. C., & Tweedy, J. R. (1992) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639208402864 · Cited by 34
Encoding Deficits in Untreated Parkinson's Disease
Cooper, J. A., & SAGAR, H. J. (1993) · Cortex · doi:10.1016/s0010-9452(13)80179-7 · Cited by 21
Fluctuations in attention: PD dementia vs DLB with parkinsonism
Godefroy, O., Roussel-Pieronne, A. R. M., & Rosa, A. E. D. (2019) · Cited by 20
Cognitive speed in nondemented Parkinson's disease
Smith, M. C., Goldman, W. P., Janer, K. W., Baty, J., & Morris, J. C. (1998) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617798466074 · Cited by 19
Psychotic symptoms in Parkinson?s disease: pathophysiology and management
Bosboom, J. L. W., & Wolters, E. C. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.3.209 · Cited by 16
Self-citation(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
A timeline for Parkinson's disease
Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Metabolic brain networks associated with cognitive function in Parkinson's disease
Huang, C., Mattis, P., Tang, C., Perrine, K., Carbon, M., & Eidelberg, D. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.09.003 · Cited by 361
Medial prefrontal cortex in neurological diseases
Xu, P., Chen, A., Li, Y., Xing, X., & Lu, H. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00006.2019 · Cited by 341
Metadata
- Authors
- Bosboom, J. L. W., Stoffers, D., & Wolters, E. C.
- Venue
- Journal of Neural Transmission
- Published
- 2004-06-30
- Volume
- 111
- Issue
- 10-11
- Pages
- 1303-1315
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2009024366
- Cited by
- 273
- References
- 122
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.